Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Advanced Prostate Cancer
Dose: Subcutaneous Injection – 1 mg (0.2 mL)
Frequency: single daily
Indication: Endometriosis
Dose: Intramuscular Injection – 3.75 mg
Frequency: monthly
Duration: up to 6 months
Note: Recommended duration of treatment is 6 months; may treat again for additional 6 months, but with concomitant administration of norethindrone

Child Dose

Clinical InformationAdministration Information
Indication: Central Precocious Puberty
Age: girls less than 8 years old and boys less than 9 years old
Dose: Subcutaneous Injection – 50 mcg/kg/day
Frequency: once daily
Note: May be titrated upward by 10 mcg/kg/day if downregulation not achieved; may be discontinued at appropriate age of onset of puberty (eg, 11 years in females and 12 years in males), at physician's discretion
Indication: Central Precocious Puberty
Age: less than 2 years old
Dose: Subcutaneous Injection – Not established
Note: Safety and efficacy not established
Administration
  • Give subcutaneously or IM
  • Follow exact schedule
Side Effect

Drug Interaction

Drug NameRisk Factors
No interactions listed
-

Disease Interaction

Disease NameRisk Factors
Undiagnosed vaginal bleeding
May mask serious condition

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.